Dose-dependent Impact of Daytime Lighting on Evening Responses to Light
1 other identifier
interventional
48
1 country
1
Brief Summary
The purpose of this study is to systematically examine the impact of different intensities of daytime light and the subsequent impact that such exposure has on non-image forming responses to light in the evening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2021
CompletedFirst Posted
Study publicly available on registry
May 11, 2021
CompletedStudy Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedMarch 17, 2022
March 1, 2022
1.9 years
May 7, 2021
March 2, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Suppression of melatonin production
Difference in salivary melatonin concentrations between active arm and 3 lux control condition
4 hours
Phase shift in the timing of melatonin onset
Change in the onset of melatonin secretion after experimental stimulus
2 days
Study Arms (4)
Low room
EXPERIMENTALLow intensity (80 lux) room light
Normal room
EXPERIMENTALNormal intensity (150 lux) room light
Bright room
EXPERIMENTALHigh intensity (500 lux) room light
Bright
EXPERIMENTALVery high intensity (1000 lux) room light
Interventions
10 hours of light exposure during the daytime, starting 2 hours after habitual wake time
Eligibility Criteria
You may qualify if:
- Aged 18-65
- Good health
- Male or female
- Normal color vision
You may not qualify if:
- Sleep disorders
- Extreme chronotypes
- Routine smoker
- Significant hearing loss
- Depressed
- Alcohol use disorder
- Use of illegal drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Palo Alto Health Care System
Palo Alto, California, 94304, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 7, 2021
First Posted
May 11, 2021
Study Start
July 1, 2022
Primary Completion
June 1, 2024
Study Completion
July 1, 2024
Last Updated
March 17, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share